Fierce Pharma

MARCH 23, 2023

AbbVie's Skyrizi aces ulcerative colitis study en route to new IBD showdown with J&J, Takeda aliu Thu, 03/23/2023 - 10:23

269

269

MedCity News

MARCH 23, 2023

GrayMatters Health recently received 510(k) clearance from the FDA to market its flagship product, which is a self-neuromodulation digital therapy for PTSD. The device uses neurofeedback on specific biomarkers to help patients identify and utilize their own mental strategy for lowering their emotional response.

FDA 126

FDA Patients Marketing 126

Fierce Pharma

MARCH 23, 2023

Fierce Pharma Asia—Takeda's $4B psoriasis data; Biohaven's neurology bet; Pfizer and Astellas' Xtandi wins aliu Thu, 03/23/2023 - 18:29

Pharma 242

Pharma 242

MedCity News

MARCH 23, 2023

Holon Solutions CEO Jon Zimmerman thinks more payers should invest in new technology to improve workloads for healthcare workers. The burnout crisis is too big for providers to solve by themselves, and many of the economic incentives for driving quality and efficiency in healthcare are housed within health plans and accountable care organizations, he said.

Healthcare 125

Healthcare Healthcare 125

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Pharma

MARCH 23, 2023

England's NICE signs off on PTC Therapeutics' $3.

260

260

Fierce Pharma

MARCH 23, 2023

Cidara gains first FDA approval, $20M milestone payment as FDA endorses Rezzayo kdunleavy Thu, 03/23/2023 - 10:51

FDA 146

FDA 146

MedCity News

MARCH 23, 2023

Of the more than 15% of American adults who have past-due medical debt, about 73% owe some or all of the money to hospitals, according to a recent Urban Institute report. The American Hospital Association said short-term limited duration health plans and high-deductible health plans are to blame.

Medical 113

Medical 113

Medgadget

MARCH 23, 2023

Researchers at Eindhoven University of Technology in the Netherlands have developed a sensitive diagnostic test for viral pathogens that is suitable for use in low-resource regions. The test is based on CRISPR proteins that can detect viral genetic material but also incorporates luciferase proteins, which are bioluminescent proteins that are naturally found in fireflies and other creatures.

Healthcare 106

Healthcare Healthcare Medicine 106

MedCity News

MARCH 23, 2023

At the AHIP Medicare, Medicaid, Duals and Commercial Markets Forum held last week, two healthcare leaders from the Centers for Medicare and Medicaid Services (CMS) and CVS Health stressed that reducing maternal health disparities is a top priority, with several strategies at play. For CMS, the focus is on encouraging states to extend Medicaid postpartum coverage, while CVS Health is working to leverage doulas in their care delivery.

Healthcare 105

Healthcare Healthcare Marketing 105

Pharmaceutical Technology

MARCH 23, 2023

Biohaven has purchased the exclusive global rights for oral, brain-penetrant dual Tyrosine Kinase 2 (TYK2)/Janus Kinase 1 (JAK1) inhibitor, BHV-8000 (previously TLL-041), which treats immune-mediated brain disorders , from Hangzhou Highlightll Pharmaceutical. The deal gives Biohaven global rights for the development of BHV-8000, excluding regions of China.

Pharmaceutical 105

Pharmaceutical Safety 105

Medgadget

MARCH 23, 2023

Levels has done something truly transformative: the company made continuous glucose monitors (CGMs) accessible to the general population and every day consumer. In many circles, it seems the trend of bringing healthcare to the home and directly to the patient is continuing, but understanding metabolism and lifestyle habits through this new tech trend of smart, wearable devices adds another important component to enjoying improved health and well-being.

Food 102

Food Education Healthcare Healthcare 102

Pharmaceutical Technology

MARCH 23, 2023

The US Food and Drug Administration (FDA) has approved Incyte ’s Zynyz (retifanlimab-dlwr) to treat metastatic or recurrent locally advanced merkel cell carcinoma (MCC) in adult patients. The regulator granted approval for Zynyz’s Biologics License Application (BLA) under accelerated approval based on the duration of response (DOR) and tumour response rate.

FDA 98

FDA Food and Drug Administration Patients Healthcare 98

MedCity News

MARCH 23, 2023

Alzheimer’s disease research at MIT spawned Cognito Therapeutics, a startup whose medical device uses light and sound to modulate electrical activity that supports brain health. The company’s Series B financing will support a Phase 3 test of its technology in patients with mild-to-moderate disease.

Patients 94

Patients Medical Biopharma 94

European Pharmaceutical Review

MARCH 23, 2023

Key data from the BOREAS Phase III trial, the first out of two Phase III trials in the Dupixent ® (dupilumab) development programme, has shown that o f 939 adult patients, 30 percent experienced reduction in moderate or severe acute chronic obstructive pulmonary disease (COPD) exacerbations over 52 weeks. The fully human monoclonal antibody is the first and only biologic to demonstrate significant improvements in lung function.

Pharmaceutical 76

Pharmaceutical Patients Safety 76

PharmaTimes

MARCH 23, 2023

Eladocagene exuparvovec is for children with ultra-rare genetic disorder in final draft guidance

94

94

European Pharmaceutical Review

MARCH 23, 2023

In final draft guidance by the National Institute for Health and Care Excellence (NICE), single dose gene therapy Upstaza (eladocagene exuparvovec) has been recommended for patients over 18 months old with severe aromatic L-amino acid decarboxylase (AADC) deficiency. How is the gene therapy administered? Designed to correct the underlying genetic defect for the condition, Upstaza is the first gene therapy to be infused directly into the brain through a minimally invasive procedure.

Pharmaceutical 71

Pharmaceutical Medicine Healthcare Healthcare 71

PharmaTimes

MARCH 23, 2023

The partnership will involve progressing macrophage-targeting antibody treatment for cancer

89

89

European Pharmaceutical Review

MARCH 23, 2023

Through its investment of approximately £600 million, Takeda plans to build a new manufacturing facility for plasma-derived therapies (PDTs) in Osaka, Japan. This is Takeda’s largest ever investment in manufacturing capacity expansion and will be the largest facility of its kind in Japan. This is Takeda’s largest ever investment in manufacturing capacity expansion and will be the largest facility of its kind in Japan.” “The new facility will provide a plasma fractionation capacity of more

Manufacturing 60

Manufacturing Pharmaceutical Medicine Patients 60

Pharmaceutical Technology

MARCH 23, 2023

Pfizer recently announced an agreement to acquire Seagen, a biotech company based in the US with four marketed oncology therapeutic agents and a rich pipeline. The deal, expected to be completed by the end of 2023, will see Pfizer pay $229 per Seagen share in cash for a total of $43bn, the largest deal for the sector in the past three years. Seagen specialises in developing antibody-drug conjugates (ADCs) which will complement Pfizer’s oncology portfolio.

Patients 59

Patients FDA Sales Engineering 59

Copyright Clearance Center

MARCH 23, 2023

The post U.S. Copyright Office Launches AI Initiative, Including New Registration Guidance appeared first on Copyright Clearance Center.

69

69

Pharmaceutical Technology

MARCH 23, 2023

This week, the Medicines and Healthcare products Regulatory Agency (MHRA) is introducing major changes to clinical trial regulation in the UK with expedited timelines at several stages. The MHRA hopes this new framework “will remove obstacles to innovation” and “streamline the regulation of clinical trials” amongst other things. These changes come following a public consultation with the Healthcare Research Authority, to which a government response was published on March 21.

Healthcare 59

Healthcare Healthcare Patients Pharmaceutical 59

Scott’s Directories

MARCH 23, 2023

Lead generation has created quite a buzz amongst marketers and business owners. As popular as it might be getting, its efficiency still depends on coming up with a robust, comprehensive strategy. How is a lead generation strategy created? How can lead generation companies help transform the way businesses sell their products and services, especially healthcare lead generation companies ?

Leads 52

Leads Healthcare Healthcare Medical 52

Pharmaceutical Technology

MARCH 23, 2023

The biotech initial public offering (IPO) market saw a 79% decline in the number of completed IPOs from 2021 to 2022 in the US; however, this comes after the IPO boom in 2020 and 2021, according to GlobalData’s Pharma Intelligence Center Deals Database. An initial public offering is a process in which a private company sells its shares on the stock exchange to become public.

Pharma 59

Pharma Pharmaceutical Medicine Marketing 59

PharmaTech

MARCH 23, 2023

Wurster Fluid Bed Coating is one of the most utilized processes for microencapsulation of fine particles in pharmaceutical, dietary supplement, food, and other industries. Jared McDonald walks through a brief history of the invention of the process, what it is, and how it can be used to address specific needs for a product. A discussion of the importance of choosing an experienced CDMO follows.

Manufacturing 52

Manufacturing Pharmaceutical Food 52

Pharma Leaders

MARCH 23, 2023

Dunagin Pharmaceuticals of Rogers, Ark., received an FDA warning letter for manufacturing drugs on the same equipment used to manufacture non-drug products and failing to test samples of product components for its pharmaceutical and nonpharmaceutical dental care products, among other lapses. The company, which does business under the name Massco Dental, must either discontinue manufacturing drugs on shared equipment or provide a plan showing how it will separate the areas in which it will “maint

FDA 52

FDA Manufacturing Pharmaceutical manufacturing Pharmaceutical 52

Pharma Marketing Network

MARCH 23, 2023

Healthcare conferences have undergone significant changes since 2020 due to the COVID-19 pandemic. Prior to the pandemic, healthcare conferences were typically large in-person events, attracting thousands of attendees from around the world. However, with the outbreak of the virus and the need for social distancing, traditional in-person events have been disrupted, forcing the healthcare industry to find new ways to connect, share information, and collaborate.

Pharmaceutical 52

Pharmaceutical Healthcare Healthcare Pharma 52

PharmaVoice

MARCH 23, 2023

The clinical data space is rapidly changing the face of the industry, GSK's Mayank Anand said — and the way organizations adopt technology is a critical part of the equation.

52

52

Pharma Marketing Network

MARCH 23, 2023

Pharmaceutical companies have made major strides in developing new treatments for Alzheimer’s disease, offering hope for the millions of people affected by this debilitating condition. Alzheimer’s is a progressive brain disorder that destroys memory and cognitive abilities, and currently there is no cure. However, recent advancements in research have resulted in new drugs that show promising results in slowing the progression of the disease.

Food and Drug Administration 52

Food and Drug Administration Pharma FDA Patients 52

Progressive Medical

MARCH 23, 2023

Progressive Medical Awarded National Agreement with Premier Inc. PMI is pleased to announce that it has been awarded a […] The post Progressive Medical, Inc. Awarded Drug Reconstitution and Transfer Devices Agreement with Premier, Inc. appeared first on Progressive Medical, Inc.

Medical 52

Medical 52

Pharma Marketing Network

MARCH 23, 2023

Pharmaceutical advertising is a crucial aspect of promoting and marketing drugs to the public. With the increase in competition, it has become essential for pharmaceutical companies to find the most effective methods of advertisement to reach their target audience. In this article, we will discuss the most effective types of advertisement in the pharmaceutical industry and provide examples and statistics to support our findings. 1.

Pharma 52

Pharma Pharmaceutical Healthcare Healthcare 52

Pharma Leaders

MARCH 23, 2023

Dewpoint Therapeutics has formed a research and development partnership with Novo Nordisk for identifying drug candidates to treat insulin resistance and diabetic complications. Dewpoint’s discovery platform related to biomolecular condensates will be used to identify the drug candidates. The collaboration will enable combination of Novo Nordisk’s expertise in treating diabetes and metabolic diseases and Dewpoint’s discovery and artificial intelligence (AI) technology platform to detect modulato

Sales 52

Sales Leads 52

Pharma Marketing Network

MARCH 23, 2023

The Food and Drug Administration (FDA) has recently approved a new drug for the treatment of Alzheimer’s disease called Leqembi. This approval marks a major milestone in the fight against Alzheimer’s, which is the sixth leading cause of death in the United States and affects over 5 million people. Leqembi, developed by pharmaceutical company Biohaven, is an oral treatment that is designed to target the root cause of Alzheimer’s, which is the accumulation of a protein called bet

Food and Drug Administration 52

Food and Drug Administration FDA Patients Pharma 52

Pharmaceutical Technology

MARCH 23, 2023

Mass spectrometry is a powerful analytical tool used to determine the composition of gases and vapours in a closed environment through highly sensitive measurements of their molecular mass. When freeze drying sterile pharmaceuticals, mass spectrometry helps manufacturers protect valuable batches from silicone oil contamination – a possible risk of the lyophilisation process.

Pharmaceutical 52

Pharmaceutical Pharma Manufacturing Medicine 52